Bret A. Lashner
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Eosinophilic Esophagitis, Liver Diseases and Immunity, Helicobacter pylori-related gastroenterology studies
Most-Cited Works
- → Infliximab Maintenance Therapy for Fistulizing Crohn's Disease(2004)2,201 cited
- → Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial(2007)611 cited
- → Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease(2006)547 cited
- → Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease(2000)459 cited
- → The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response?(2010)407 cited
- → A Randomized Clinical Trial of Ciprofloxacin and Metronidazole to Treat Acute Pouchitis(2001)347 cited
- → Cytomegalovirus Colitis Complicating Inflammatory Bowel Disease(2006)339 cited
- → Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis(1989)324 cited
- → Modified Pouchitis Disease Activity Index(2003)286 cited
- → Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial.(1997)280 cited